1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o, p'-DDT affects the expression of CYP3A23-3A1 mRNA CTD PMID:17984292 1,2,4-trichlorobenzene increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of 1 more ... CTD PMID:2017752 1,2-dichloroethene decreases activity EXP 6480464 1, 2-dichloroethylene results in decreased activity of CYP3A23-3A1 protein CTD PMID:9493318 1,2-dichloroethene decreases expression EXP 6480464 1, 2-dichloroethylene results in decreased expression of CYP3A23-3A1 protein CTD PMID:9493318 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12883083 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10707959 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23770461 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:23770461 , PMID:24878560 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:16107549 more ... 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [CYP3A23-3A1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,2',4,4'-Tetrabromodiphenyl ether increases oxidation EXP 6480464 CYP3A23-3A1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 NR1I3 gene mutant form inhibits the reaction [2 more ... CTD PMID:23770461 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23770461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16054898 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 [CYP3A23-3A1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases oxidation EXP 6480464 CYP3A23-3A1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:16107549 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA, 2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 protein CTD PMID:12504080 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA more ... CTD PMID:12504080 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP3A23-3A1 mRNA CTD PMID:23273579 3-oxo-5beta-cholanic acid multiple interactions EXP 6480464 [CYP3A23-3A1 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis of 3-oxocholan-24-oic acid CTD PMID:18039809 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:19162173 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone decreases activity EXP 6480464 musk ketone results in decreased activity of CYP3A23-3A1 protein CTD PMID:10630706 4-nitrophenol increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of 4-nitrophenol CTD PMID:11911841 4-nonylphenol multiple interactions EXP 6480464 4-nonylphenol promotes the reaction [NR1I2 protein results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:17483497 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19118567 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 acetonitrile multiple interactions EXP 6480464 acetonitrile inhibits the reaction [CYP3A23-3A1 protein results in increased metabolism of 7-benzyloxyquinoline] CTD PMID:19858067 Acetyl tributyl citrate increases expression EXP 6480464 2-acetyltributylcitrate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:21742782 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:28959563 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP3A23-3A1 mRNA], Dactinomycin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:11181506 alachlor increases expression EXP 6480464 alachlor results in increased expression of CYP3A23-3A1 mRNA CTD PMID:14613717 alkaloid multiple interactions EXP 6480464 Alkaloids inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP3A23-3A1 protein], Alkaloids inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:21224420 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16940010 alpha-Hydroxyalprazolam affects chemical synthesis EXP 6480464 CYP3A23-3A1 protein affects the chemical synthesis of alpha-hydroxyalprazolam CTD PMID:12196913 alprazolam affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of Alprazolam CTD PMID:12196913 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CYP3A23-3A1 mRNA CTD PMID:18355885 , PMID:19483382 amitraz increases expression EXP 6480464 amitraz results in increased expression of CYP3A23-3A1 protein CTD PMID:31029719 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10945841 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of CYP3A23-3A1 mRNA CTD PMID:18355885 andrographolide decreases expression EXP 6480464 andrographolide results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:19041297 anthocyanin increases expression EXP 6480464 Anthocyanins results in increased expression of CYP3A23-3A1 mRNA CTD PMID:18803703 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A23-3A1 mRNA, Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A23-3A1 protein CTD PMID:11163329 more ... arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [Rifampin results in increased expression of and results in increased activity of CYP3A23-3A1 protein], arsenite inhibits the reaction [Rifampin results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:22159698 atorvastatin calcium multiple interactions EXP 6480464 [Dietary Fats co-treated with Atorvastatin] results in increased expression of CYP3A23-3A1 protein CTD PMID:26616219 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 benzene decreases expression EXP 6480464 Benzene results in decreased expression of CYP3A23-3A1 CTD PMID:9010585 benzophenone increases expression EXP 6480464 benzophenone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:14613717 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:19041297 beta-naphthoflavone multiple interactions EXP 6480464 [Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP3A23-3A1 protein, diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A23-3A1 protein] CTD PMID:26880746 , PMID:30842367 beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP3A23-3A1 protein CTD PMID:26880746 bexarotene decreases expression EXP 6480464 Bexarotene results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:16648578 bexarotene increases expression EXP 6480464 Bexarotene results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16648578 , PMID:23292798 bilirubin IXalpha multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of Bilirubin CTD PMID:34461081 bilobalide multiple interactions EXP 6480464 bilobalide results in increased expression of and results in increased activity of CYP3A23-3A1 protein CTD PMID:18421621 bilobalide increases expression EXP 6480464 bilobalide results in increased expression of CYP3A23-3A1 mRNA CTD PMID:18421621 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of CYP3A23-3A1 protein CTD PMID:11169160 , PMID:11285203 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10707959 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP3A23-3A1 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CYP3A23-3A1 gene CTD PMID:28505145 bitertanol increases expression EXP 6480464 bitertanol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16971034 Bromadiolone decreases response to substance EXP 6480464 CYP3A23-3A1 protein results in decreased susceptibility to bromadiolone CTD PMID:18080289 bromuconazole increases expression EXP 6480464 bromuconazole results in increased expression of CYP3A23-3A1 CTD PMID:28532222 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:20006981 calcitriol multiple interactions EXP 6480464 Chenodeoxycholic Acid inhibits the reaction [Calcitriol results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:20006981 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of CYP3A23-3A1 mRNA, Capsaicin results in decreased expression of CYP3A23-3A1 protein CTD PMID:24013073 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of CYP3A23-3A1 mRNA CTD PMID:17381134 carvedilol increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of Carvedilol CTD PMID:29415952 chalcone increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of Chalcone CTD PMID:15863696 chenodeoxycholic acid multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of Chenodeoxycholic Acid more ... CTD PMID:20006981 , PMID:34461081 chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:20006981 chloroform decreases expression EXP 6480464 Chloroform results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:15120965 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:30744511 chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of CYP3A23-3A1 protein CTD PMID:15587241 chlorpyrifos affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of Chlorpyrifos CTD PMID:15587241 chlorzoxazone increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of Chlorzoxazone CTD PMID:11911841 chlorzoxazone affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 cholesterol multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in decreased abundance of Cholesterol CTD PMID:34461081 cholic acid multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of Cholic Acid CTD PMID:34461081 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CYP3A23-3A1 protein CTD PMID:24403518 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10215695 ciprofibrate multiple interactions EXP 6480464 INS protein affects the reaction [ciprofibrate results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:10215695 ciprofloxacin decreases expression EXP 6480464 Ciprofloxacin results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:12621481 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of CYP3A23-3A1 mRNA CTD PMID:20623750 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:11328961 more ... clofibrate multiple interactions EXP 6480464 Clofibrate promotes the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A23-3A1 protein] CTD PMID:15826607 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP3A23-3A1 mRNA more ... CTD PMID:15788368 , PMID:17602206 clofibric acid increases expression EXP 6480464 Clofibric Acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:15788368 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of CYP3A23-3A1 mRNA CTD PMID:18355885 clothianidin multiple interactions EXP 6480464 [enilconazole co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA, [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33426623 clothianidin increases expression EXP 6480464 clothianidin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33426623 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12971794 , PMID:16125621 clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [CYP3A23-3A1 protein results in increased metabolism of 7-benzyloxyquinoline] CTD PMID:19858067 cocaine affects expression EXP 6480464 Cocaine affects the expression of CYP3A23-3A1 mRNA CTD PMID:20187946 cordycepin multiple interactions EXP 6480464 cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:11181506 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:35301062 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP3A23-3A1 mRNA, Corticosterone results in increased expression of CYP3A23-3A1 protein CTD PMID:35301062 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CYP3A23-3A1 mRNA, Hydrocortisone results in increased expression of CYP3A23-3A1 protein CTD PMID:10476907 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:11181506 cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of CYP3A23-3A1 mRNA CTD PMID:18246545 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:18246545 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:29727961 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP3A23-3A1 mRNA, cypermethrin results in increased expression of CYP3A23-3A1 protein CTD PMID:25288152 cypermethrin multiple interactions EXP 6480464 cypermethrin promotes the reaction [cypermethrin results in increased expression of CYP3A23-3A1 mRNA], cypermethrin promotes the reaction [cypermethrin results in increased expression of CYP3A23-3A1 protein] CTD PMID:25288152 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:25182419 , PMID:29038839 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA more ... CTD PMID:29038839 cyproconazole increases activity EXP 6480464 cyproconazole results in increased activity of CYP3A23-3A1 protein CTD PMID:25182419 , PMID:29038839 DDD increases expression EXP 6480464 Dichlorodiphenyldichloroethane results in increased expression of CYP3A23-3A1 mRNA CTD PMID:21259292 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP3A23-3A1 mRNA, Dichlorodiphenyl Dichloroethylene results in increased expression of CYP3A23-3A1 protein CTD PMID:12869653 DDE multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CYP3A23-3A1 mRNA, decabromobiphenyl ether results in increased expression of CYP3A23-3A1 protein CTD PMID:20686340 , PMID:32679240 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16940010 deoxycholic acid multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of Deoxycholic Acid CTD PMID:34461081 dexamethasone multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 mRNA] more ... CTD PMID:10329507 more ... dexamethasone increases activity EXP 6480464 Dexamethasone results in increased activity of CYP3A23-3A1 protein CTD PMID:19118567 , PMID:26880746 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP3A23-3A1 mRNA, Dexamethasone results in increased expression of CYP3A23-3A1 protein CTD PMID:10329507 more ... dextromethorphan affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of Dextromethorphan CTD PMID:15879494 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10945841 more ... dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A23-3A1 protein] more ... CTD PMID:26880746 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP3A23-3A1 mRNA, Dibutyl Phthalate results in increased expression of CYP3A23-3A1 protein CTD PMID:15901914 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19022234 , PMID:29027214 dicofol increases expression EXP 6480464 Dicofol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19595748 diflubenzuron increases expression EXP 6480464 Diflubenzuron results in increased expression of CYP3A23-3A1 protein CTD PMID:8812189 dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [CYP3A23-3A1 protein results in increased metabolism of 7-benzyloxyquinoline] CTD PMID:19858067 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:17481689 diuron increases expression EXP 6480464 Diuron results in increased expression of CYP3A23-3A1 protein CTD PMID:8812189 enilconazole multiple interactions EXP 6480464 [enilconazole co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA, [thiacloprid co-treated with enilconazole] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33426623 enilconazole increases expression EXP 6480464 enilconazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33426623 epoxiconazole increases activity EXP 6480464 epoxiconazole results in increased activity of CYP3A23-3A1 protein CTD PMID:25182419 , PMID:29038839 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA more ... CTD PMID:29038839 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:25182419 , PMID:29038839 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12883083 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:15353170 more ... ethanol multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:35301062 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19695238 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP3A23-3A1 protein CTD PMID:15840382 felbamate increases expression EXP 6480464 Felbamate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:17381134 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:18253720 fenvalerate multiple interactions EXP 6480464 Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A23-3A1 mRNA], fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:20599767 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:20599767 fipronil increases expression EXP 6480464 fipronil results in increased expression of CYP3A23-3A1 mRNA CTD PMID:22447239 , PMID:23962444 fipronil-sulfone increases expression EXP 6480464 fipronil sulfone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:22447239 fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16643972 fluconazole affects expression EXP 6480464 Fluconazole affects the expression of CYP3A23-3A1 mRNA CTD PMID:20623750 Furafylline decreases activity EXP 6480464 furafylline results in decreased activity of CYP3A23-3A1 protein CTD PMID:15879494 furan decreases expression EXP 6480464 furan results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:15120968 more ... gabapentin decreases expression EXP 6480464 Gabapentin results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:17381134 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP3A23-3A1 mRNA CTD PMID:14613717 , PMID:25572523 gamma-hexachlorocyclohexane affects expression EXP 6480464 Hexachlorocyclohexane affects the expression of CYP3A23-3A1 mRNA CTD PMID:22001173 genistein multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [Genistein results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:32185415 genistein increases expression EXP 6480464 Genistein results in increased expression of CYP3A23-3A1 mRNA CTD PMID:32185415 gentamycin affects expression EXP 6480464 Gentamicins affects the expression of CYP3A23-3A1 mRNA CTD PMID:20623750 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33387578 Ginkgolide A increases activity EXP 6480464 ginkgolide A results in increased activity of CYP3A23-3A1 protein CTD PMID:17045319 Ginkgolide A increases expression EXP 6480464 ginkgolide A results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16258077 , PMID:17045319 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:24136188 glutathione multiple interactions EXP 6480464 [CYP3A23-3A1 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1 more ... CTD PMID:20825217 hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of CYP3A23-3A1 mRNA CTD PMID:15159207 huperzine A increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of huperzine A CTD PMID:12586202 ifosfamide increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of Ifosfamide CTD PMID:15919850 imipramine affects expression EXP 6480464 Imipramine affects the expression of CYP3A23-3A1 mRNA CTD PMID:18355885 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:24418717 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:24418717 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:16771604 , PMID:29027214 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12883083 isoniazide increases activity EXP 6480464 Isoniazid results in increased activity of CYP3A23-3A1 protein CTD PMID:26880746 isoniazide multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Isoniazid results in increased activity of CYP3A23-3A1 protein] CTD PMID:26880746 ketamine increases expression EXP 6480464 Ketamine results in increased expression of CYP3A23-3A1 protein CTD PMID:16076768 ketoconazole multiple interactions EXP 6480464 [Strychnine co-treated with Ketoconazole] results in decreased expression of CYP3A23-3A1 protein more ... CTD PMID:19858067 more ... ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP3A23-3A1 protein CTD PMID:12814958 , PMID:15879494 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of CYP3A23-3A1 mRNA CTD PMID:18355885 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CYP3A23-3A1 protein CTD PMID:24403518 lactacystin multiple interactions EXP 6480464 lactacystin inhibits the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 protein] CTD PMID:17083955 lamotrigine increases glutathionylation EXP 6480464 CYP3A23-3A1 protein results in increased glutathionylation of Lamotrigine CTD PMID:19961160 Lasiocarpine increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of lasiocarpine CTD PMID:31103741 leflunomide increases expression EXP 6480464 Leflunomide results in increased expression of CYP3A23-3A1 mRNA CTD PMID:24136188 lithocholic acid multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] affects the abundance of Lithocholic Acid more ... CTD PMID:18039809 more ... lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:20006981 , PMID:20888898 lithocholic acid increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of Lithocholic Acid CTD PMID:18039809 mangiferin decreases activity EXP 6480464 mangiferin results in decreased activity of CYP3A23-3A1 protein CTD PMID:18053976 metazachlor increases expression EXP 6480464 metazachlor results in increased expression of CYP3A23-3A1 mRNA CTD PMID:31465819 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:15120968 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:15120968 , PMID:29027214 methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP3A23-3A1 protein CTD PMID:15879494 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP3A23-3A1 mRNA CTD PMID:14613717 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:30744511 miconazole increases expression EXP 6480464 Miconazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12971794 midazolam increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of Midazolam CTD PMID:11911841 mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16125621 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of CYP3A23-3A1 mRNA CTD PMID:32682830 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP3A23-3A1 mRNA CTD PMID:21515302 musk xylene increases activity EXP 6480464 musk xylene results in increased activity of CYP3A23-3A1 protein CTD PMID:10630706 musk xylene increases expression EXP 6480464 musk xylene results in increased expression of CYP3A23-3A1 protein CTD PMID:10630706 N'-(2,4-dimethylphenyl)-N-methylformamidine increases expression EXP 6480464 U 40481 results in increased expression of CYP3A23-3A1 protein CTD PMID:31029719 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 mRNA], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 protein] CTD PMID:17083955 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA more ... CTD PMID:14656948 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:19638242 , PMID:20360939 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of CYP3A23-3A1 protein CTD PMID:16997515 N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP3A23-3A1 mRNA CTD PMID:22037397 NADP zwitterion multiple interactions EXP 6480464 [CYP3A23-3A1 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1 more ... CTD PMID:20825217 NADP(+) multiple interactions EXP 6480464 [CYP3A23-3A1 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1 more ... CTD PMID:20825217 nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16408618 nemorubicin increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of methoxy-morpholinyl-doxorubicin CTD PMID:15465924 nevirapine affects binding EXP 6480464 Nevirapine binds to CYP3A23-3A1 protein CTD PMID:22793666 nevirapine increases expression EXP 6480464 Nevirapine results in increased expression of CYP3A23-3A1 mRNA CTD PMID:23947594 nicardipine increases expression EXP 6480464 Nicardipine results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16125621 nifedipine increases expression EXP 6480464 Nifedipine results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16125621 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10707959 obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:35267068 octamethylcyclotetrasiloxane increases expression EXP 6480464 octamethylcyclotetrasiloxane results in increased expression of CYP3A23-3A1 protein CTD PMID:15849718 okadaic acid multiple interactions EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of and results in increased hydroxylation of and results in decreased susceptibility to Okadaic Acid more ... CTD PMID:23770461 , PMID:26374342 oltipraz affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of oltipraz CTD PMID:15831204 , PMID:15920769 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19118567 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of CYP3A23-3A1 mRNA, Oxycodone results in increased expression of CYP3A23-3A1 protein CTD PMID:23439660 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12883083 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:15120968 , PMID:18246545 Paraoxon-methyl increases chemical synthesis EXP 6480464 CYP3A23-3A1 protein results in increased chemical synthesis of methylparaoxon CTD PMID:22271348 parathion-methyl increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of Methyl Parathion CTD PMID:22271348 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23770461 PCB138 multiple interactions EXP 6480464 NR1I3 gene mutant form inhibits the reaction [2 more ... CTD PMID:23770461 pentachlorobenzene increases metabolic processing EXP 6480464 CYP3A23-3A1 protein results in increased metabolism of pentachlorobenzene CTD PMID:2017752 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of CYP3A23-3A1 protein CTD PMID:8812189 perfluorobutyric acid increases expression EXP 6480464 perfluorobutyric acid analog results in increased expression of CYP3A23-3A1 mRNA CTD PMID:21878386 perfluorodecanoic acid multiple interactions EXP 6480464 perfluorodecanoic acid inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A23-3A1 protein] CTD PMID:15826607 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:34460931 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of CYP3A23-3A1 mRNA CTD PMID:17383973 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid analog results in increased expression of CYP3A23-3A1 protein, perfluorooctane sulfonic acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:18692542 more ... perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of CYP3A23-3A1 mRNA CTD PMID:17383973 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP3A23-3A1 mRNA, perfluorooctanoic acid results in increased expression of CYP3A23-3A1 protein CTD PMID:20614104 more ... permethrin increases expression EXP 6480464 Permethrin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:11377398 , PMID:29477483 permethrin multiple interactions EXP 6480464 EGF protein inhibits the reaction [Permethrin results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:11377398 phenacetin affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of Phenacetin CTD PMID:15879494 phenobarbital multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of CYP3A23-3A1 mRNA more ... CTD PMID:10215695 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP3A23-3A1 mRNA, Phenobarbital results in increased expression of CYP3A23-3A1 protein CTD PMID:10036216 more ... phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP3A23-3A1 protein CTD PMID:19118567 , PMID:25182419 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:17381134 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10945841 , PMID:17381134 phthalic acid increases expression EXP 6480464 phthalic acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10707959 pioglitazone increases expression EXP 6480464 Pioglitazone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16597547 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:19850644 poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:23939143 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile multiple interactions EXP 6480464 [Dietary Fats co-treated with Pregnenolone Carbonitrile] results in increased expression of CYP3A23-3A1 protein more ... CTD PMID:11752103 more ... pregnenolone 16alpha-carbonitrile increases activity EXP 6480464 Pregnenolone Carbonitrile results in increased activity of CYP3A23-3A1 protein CTD PMID:19118567 more ... pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP3A23-3A1 mRNA, Pregnenolone Carbonitrile results in increased expression of CYP3A23-3A1 protein CTD PMID:10772642 more ... prochloraz increases activity EXP 6480464 prochloraz results in increased activity of CYP3A23-3A1 protein CTD PMID:25182419 , PMID:29038839 prochloraz multiple interactions EXP 6480464 [prochloraz co-treated with cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA, [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein CTD PMID:29038839 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP3A23-3A1 mRNA CTD PMID:25182419 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10707959 propiconazole affects expression EXP 6480464 propiconazole affects the expression of CYP3A23-3A1 mRNA CTD PMID:17383973 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP3A23-3A1 mRNA CTD PMID:15603923 , PMID:16643972 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CYP3A23-3A1 mRNA CTD PMID:22431067 pyrene increases expression EXP 6480464 pyrene results in increased expression of CYP3A23-3A1 mRNA CTD PMID:30240548 pyridine multiple interactions EXP 6480464 cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A23-3A1 mRNA] more ... CTD PMID:11181506 pyridine increases expression EXP 6480464 pyridine results in increased expression of CYP3A23-3A1 mRNA, pyridine results in increased expression of CYP3A23-3A1 protein CTD PMID:11181506 pyridine increases activity EXP 6480464 pyridine results in increased activity of CYP3A23-3A1 protein CTD PMID:11181506 rifampicin increases expression EXP 6480464 Rifampin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19041297 , PMID:22159698 rifampicin multiple interactions EXP 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP3A23-3A1 mRNA more ... CTD PMID:12370413 more ... ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of CYP3A23-3A1 mRNA CTD PMID:17719200 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:28374803 sodium arsenite multiple interactions EXP 6480464 sodium arsenite inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of CYP3A23-3A1 mRNA] more ... CTD PMID:10329507 more ... spironolactone multiple interactions EXP 6480464 NR1I2 protein promotes the reaction [Spironolactone results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:11752103 spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:11752103 stilbene oxide increases expression EXP 6480464 stilbene oxide results in increased expression of CYP3A23-3A1 mRNA CTD PMID:10945841 strychnine multiple interactions EXP 6480464 [Strychnine co-treated with Ketoconazole] results in decreased expression of CYP3A23-3A1 protein, [Strychnine co-treated with Phenobarbital] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:35358606 Sudan III multiple interactions EXP 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A23-3A1 protein] more ... CTD PMID:15788368 Sudan III decreases expression EXP 6480464 sudan III results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:15788368 sulfoxaflor increases expression EXP 6480464 sulfoxaflor results in increased expression of CYP3A23-3A1 mRNA CTD PMID:23607986 tamoxifen increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of Tamoxifen CTD PMID:15587933 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of CYP3A23-3A1 protein CTD PMID:10959800 taurocholic acid multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of Taurocholic Acid CTD PMID:34461081 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of CYP3A23-3A1 mRNA, ethyl tert-butyl ether results in increased expression of CYP3A23-3A1 protein CTD PMID:24090815 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP3A23-3A1 mRNA CTD PMID:21515302 testosterone affects metabolic processing EXP 6480464 CYP3A23-3A1 protein affects the metabolism of Testosterone CTD PMID:15879494 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CYP3A23-3A1 mRNA CTD PMID:17805973 tetrachloromethane multiple interactions EXP 6480464 Alkaloids inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP3A23-3A1 protein] more ... CTD PMID:21224420 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP3A23-3A1 mRNA CTD PMID:21224420 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP3A23-3A1 mRNA, Carbon Tetrachloride results in decreased expression of CYP3A23-3A1 protein CTD PMID:15120965 more ... thiacloprid multiple interactions EXP 6480464 [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA, [thiacloprid co-treated with enilconazole] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33426623 thiacloprid increases expression EXP 6480464 thiacloprid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:33426623 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CYP3A23-3A1 mRNA CTD PMID:19483382 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:28943392 toremifene increases expression EXP 6480464 Toremifene results in increased expression of CYP3A23-3A1 protein CTD PMID:10959800 trabectedin multiple interactions EXP 6480464 Trabectedin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA] CTD PMID:12504080 trans-1,2-dichloroethene decreases activity EXP 6480464 1, 2-dichloroethylene results in decreased activity of CYP3A23-3A1 protein CTD PMID:9493318 trans-1,2-dichloroethene decreases expression EXP 6480464 1, 2-dichloroethylene results in decreased expression of CYP3A23-3A1 protein CTD PMID:9493318 trans-chalcone increases hydroxylation EXP 6480464 CYP3A23-3A1 protein results in increased hydroxylation of Chalcone CTD PMID:15863696 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP3A23-3A1 mRNA, triadimefon results in increased expression of CYP3A23-3A1 protein CTD PMID:16643972 more ... triadimefon affects expression EXP 6480464 triadimefon affects the expression of CYP3A23-3A1 mRNA CTD PMID:17383973 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19448997 , PMID:33387578 triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19910387 more ... trifluralin increases expression EXP 6480464 Trifluralin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:14613717 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP3A23-3A1 mRNA CTD PMID:30589522 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:33600922 Triptolide decreases activity EXP 6480464 triptolide results in decreased activity of CYP3A23-3A1 protein CTD PMID:33600922 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16597547 more ... troleandomycin increases expression EXP 6480464 Troleandomycin results in increased expression of CYP3A23-3A1 mRNA CTD PMID:12971794 uranium atom increases expression EXP 6480464 Uranium results in increased expression of CYP3A23-3A1 mRNA CTD PMID:16039771 , PMID:16231126 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CYP3A23-3A1 mRNA CTD PMID:19255942 ursodeoxycholic acid multiple interactions EXP 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of Ursodeoxycholic Acid CTD PMID:34461081 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CYP3A23-3A1 mRNA CTD PMID:24136188 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:17381134 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP3A23-3A1 mRNA, vinclozolin results in increased expression of CYP3A23-3A1 protein CTD PMID:14613717 , PMID:25929820 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP3A23-3A1 mRNA CTD PMID:27225895 zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of CYP3A23-3A1 mRNA CTD PMID:20607812
